systemic sclerosis

July 23, 2015November 6, 2015

Systemic Sclerosis Patients Found To Have Higher Risk for Temporomandibular Joint Disorder

News, Scleroderma

In a recent study, researchers observed that temporomandibular joint disorder is common in Systemic Sclerosis patients, correlating with disease severity. The findings were presented at the European League Against Rheumatism Annual European ... Read more

June 15, 2015November 6, 2015

Corbus Announces FDA Orphan Drug Designation For Resunab To Address Systemic Sclerosis

News, Scleroderma

Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug advancement company focused on addressing chronic rare and serious fibrotic inflammatory diseases, announced recently that the United States Food and Drug Administration (FDA) has granted Corbus’ lead candidate ... Read more

June 11, 2015November 6, 2015

Breakthrough Therapy Status Granted to Roche’s SSc Treatment

News, Scleroderma

Roche was recently granted breakthrough therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for its combined treatment ACTEMRA/RoACTEMRA (tocilizumab) for systemic sclerosis (SSc). The status was awarded based on successful ... Read more

June 5, 2015November 6, 2015

Accuracy of High Resolution Computed Tomography, Lung Function Tests in SSc Evaluated in New Study

News, Scleroderma

In a recent study published in the journal Arthritis & Rheumatology, researchers found that high resolution computed tomography (HRCT) predicts fibrosis development, rate of fibrosis progression and pulmonary function decline ... Read more

March 24, 2015November 6, 2015

Scleroderma Patients Have Lower Survival Rates Even with Early Lung Cancer Diagnosis

News, Scleroderma

In a recent study entitled “Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional study,” the authors characterize lung cancer profiles in Systemic ... Read more

December 10, 2014November 11, 2015

Cureveda Receives NIH Grants for Systemic Sclerosis and COPD Drug

COPD, News, Scleroderma

Biotechnology company Cureveda LLC just announced that it has received two National Institutes of Health (NIH) Phase I Small Business Technology Transfer (STTR) grants worth $450,000 in total. Cureveda specializes in ... Read more

November 20, 2014November 6, 2015

Systemic Sclerosis Patients Also Benefit from Lung Transplantation, Study Reveals

News, Scleroderma

End-stage lung disease patients suffering from systemic sclerosis should not be denied access to lung transplants based on limited survival rate concerns. Those are the conclusions of a new study ... Read more

November 17, 2014November 6, 2015

PH Therapy Riociguat To Be Tested as Diffuse Cutaneous Systemic Sclerosis Drug

News, Scleroderma

Bayer HealthCare recently announced the launch of a new clinical trial, the RISE-SSc study, a randomized, double-blind, placebo-controlled Phase II study to investigate the efficacy and safety of riociguat against placebo in ... Read more